TH1601003463A - Chromone derivatives as dopamine D3 receptor antagonists for use in the treatment of autism spectrum disorders. - Google Patents

Chromone derivatives as dopamine D3 receptor antagonists for use in the treatment of autism spectrum disorders.

Info

Publication number
TH1601003463A
TH1601003463A TH1601003463A TH1601003463A TH1601003463A TH 1601003463 A TH1601003463 A TH 1601003463A TH 1601003463 A TH1601003463 A TH 1601003463A TH 1601003463 A TH1601003463 A TH 1601003463A TH 1601003463 A TH1601003463 A TH 1601003463A
Authority
TH
Thailand
Prior art keywords
dopamine
treatment
receptor antagonists
autism spectrum
spectrum disorders
Prior art date
Application number
TH1601003463A
Other languages
Thai (th)
Other versions
TH167367A (en
TH167367B (en
Inventor
ออแคลร์นายพอล โมเซอร์นายปิแอร์ โซโคลอฟฟ์ นางสาวแอ็กเนส
Original Assignee
ปิแอร์ ฟาเบรอะ เมดิคามองต์
Filing date
Publication date
Application filed by ปิแอร์ ฟาเบรอะ เมดิคามองต์ filed Critical ปิแอร์ ฟาเบรอะ เมดิคามองต์
Publication of TH167367A publication Critical patent/TH167367A/en
Publication of TH1601003463A publication Critical patent/TH1601003463A/en
Publication of TH167367B publication Critical patent/TH167367B/en

Links

TH1601003463A 2014-12-12 Chromone derivative as an antagonist of dopamine D3 receptor for therapeutic use. TH167367B (en)

Publications (3)

Publication Number Publication Date
TH167367A TH167367A (en) 2017-09-07
TH1601003463A true TH1601003463A (en) 2017-09-07
TH167367B TH167367B (en) 2017-09-07

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201700737B (en) Cyclohexyl-ethyl substituted diaza- and triaza-tricyclic compounds as indole-amine-2,3-dioxygenase (ido) antagonists for the treatment of cancer
DK3119397T3 (en) Heterocyclic compounds for use in the treatment of PI3K-gamma-mediated disorders
DK3229810T3 (en) PHOSPHOLIPID-ETHER ANALOGES AS CANCER-DISABLING MEDICINES
BR112017001387A2 (en) Reamer.
GB201412929D0 (en) Reamer
GB2528457B (en) Reamer
DK3153508T3 (en) NAPHTHOFURAND DERIVATIVES FOR USE AS ANTICANCER AGENTS
GB2528459B (en) Reamer
IL250038A0 (en) 4,5-dihydroisoxazole derivatives as nampt inhibitors
BR112017001386A2 (en) Reamer.
GB201412931D0 (en) Reamer
DK3166473T3 (en) ophthalmoscopes
DK3122763T3 (en) ANTI-MICROBIBLE PEPTID DISORDERS
HRP20180323T8 (en) A chromone derivative as a dopamine d3 receptor antagonist for its use in the treatment of autism spectrum disorder
ZA201704462B (en) New benzimidazole derivatives as antihistamine agents
PT3160464T (en) 6-hydroxybuspirone for use in the treatment of movement disorders
HK1231482A1 (en) Antagonists acting at multiple prostaglandin receptors for the treatment of inflammation
DK2915526T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
DK3096839T3 (en) FRAGRANT COMPOSITIONS FOR THE BODY
TH1601003463A (en) Chromone derivatives as dopamine D3 receptor antagonists for use in the treatment of autism spectrum disorders.
PL3164110T3 (en) Pharmaceutical compositions for the treatment of psoriasis
GB2528455B (en) Reamer
AP2017009784A0 (en) Anthostema senegalense-based composition, for use as an anti-aids drug
ITUB20155450A1 (en) Composition for the treatment of dermatitis.
TH1501005076A (en) Agent for flavoring hydrogenated oils